Non-Hodgkin Lymphoma — Trials

Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

8,119 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,168
Recruiting: 1,128
Ph III recruiting: 115
Growth YoY: +8.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%
Trials / 1,000 deaths: 108.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,289)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00038818	CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation	terminated	N/A	3	M.D. Anderson Cancer CenterOTHER	1	Aug 23, 2012	clinicaltrials
NCT00161239	LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma	terminated	N/A	64	University of Medicine and Dentistry of New JerseyOTHER	1	Dec 11, 2009	clinicaltrials